August 19, 2025 AAP Vaccine Recommendations Veer From ACIP AAP released 2025 evidence-based US childhood and adolescent immunization schedule with updates for RSV, influenza, COVID-19, HPV, and meningococcal vaccines. Conexiant
August 14, 2025 Does Exposure to Wildfire-Dominated, Inhalable, Fine Particulate Matter Impact Survival in NSCLC? The ASCO Post
June 13, 2025 HER3-Targeted Antibody-Drug Conjugate for Treatment-Resistant Solid Tumors The ASCO Post
June 30, 2025 Structured Exercise Program Improves Survival Outcomes in Patients With Stage III or High-Risk Stage II Colon Cancer The ASCO Post
November 17, 2023 Extensive-Stage Small Cell Lung Cancer: Triplet Combination vs Chemotherapy Alone The ASCO Post
November 16, 2023 EGFR Tyrosine Kinase Inhibitors vs Durvalumab in EGFR-Mutated NSCLC: Impact on Survival The ASCO Post
November 17, 2023 Taiwanese Program Shows Potential for Detecting Early-Stage Lung Cancer The ASCO Post
November 24, 2024 TROPION-Lung01 Update: Dato-DXd Shows Activity in Previously Treated Advanced Nonsquamous NSCLC The ASCO Post
November 24, 2024 Use of Aumolertinib Extends Progression-Free Survival in Stage III EGFR-Mutated NSCLC The ASCO Post
October 24, 2024 New Hope for Patients With HER2-Mutant NSCLC: Durable Responses to Two Novel Targeted Therapies The ASCO Post
August 15, 2025 Studies on EGFR Mutations and NRG1 Fusions Included in ASCO NSCLC Living Guideline Update The ASCO Post
August 15, 2025 Approved: HPV-Targeted Immunotherapy for Recurrent Respiratory Papillomatosis Conexiant